158 related articles for article (PubMed ID: 29441886)
1. Effects and mechanisms of ambroxol inhalation (Mucosolvan
Yang Z; Xiao X; Huang Y; He X; Lu Q; Chen S; Lin Z
Pharmazie; 2017 Oct; 72(10):604-607. PubMed ID: 29441886
[TBL] [Abstract][Full Text] [Related]
2. Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1/2 signaling pathway.
Zhang SJ; Jiang JX; Ren QQ; Jia YL; Shen J; Shen HJ; Lin XX; Lu H; Xie QM
Eur J Pharmacol; 2016 Mar; 775():138-48. PubMed ID: 26872986
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic efficacy of high-dose ambroxol and the nursing effects in the treatment of severe pneumonia.
Wang D; Sun S; Hu S
Pak J Pharm Sci; 2019 May; 32(3 Special):1409-1413. PubMed ID: 31551222
[TBL] [Abstract][Full Text] [Related]
4. [Use of mucolytic preparations (Mucosolvan) in selected diseases of the upper respiratory tract. Part II].
Szmeja Z; Golusiński W; Mielcarek-Kuchta D; Laczkowska-Przybylska J
Otolaryngol Pol; 1997; 51(5):480-6. PubMed ID: 9557050
[TBL] [Abstract][Full Text] [Related]
5. [Inhalation and peroral mucolytic therapy in mucoviscidosis in children].
Uglitskikh AK; Khan MA; Sharapov SV; Kapranov NI; Plisko LF
Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):15-8. PubMed ID: 9036657
[TBL] [Abstract][Full Text] [Related]
6. Oxygen-driving and atomized mucosolvan inhalation combined with holistic nursing in the treatment of children severe bronchial pneumonia.
Yang F
Pak J Pharm Sci; 2015 Jul; 28(4 Suppl):1477-80. PubMed ID: 26431648
[TBL] [Abstract][Full Text] [Related]
7. Mucosolvan serves to optimize perioperative airway management for NSCLC patients in fast track surgery: a randomized placebo controlled study.
Wang JY; Hong X; Chen GH; Li QC; Liu ZM
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2875-81. PubMed ID: 26241543
[TBL] [Abstract][Full Text] [Related]
8. [Antenatal ambroxol administration for prevention of respiratopry distress syndrome in preterm infants: preliminary report].
Marinov B; Jekova N; Andreeva A; Hitrova S
Akush Ginekol (Sofiia); 2011; 50(4):17-22. PubMed ID: 22479892
[TBL] [Abstract][Full Text] [Related]
9. Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
Schmalisch G; Wauer RR; Böhme B
Respir Med; 2000 Apr; 94(4):378-84. PubMed ID: 10845438
[TBL] [Abstract][Full Text] [Related]
10. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
[TBL] [Abstract][Full Text] [Related]
11. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
12. [The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients].
Jahnz-Rózyk K; Kucharczyk A; Chciałowski A; Płusa T
Pol Merkur Lekarski; 2001 Sep; 11(63):239-43. PubMed ID: 11761819
[TBL] [Abstract][Full Text] [Related]
13. Antenatal use of ambroxol for the prevention of infant respiratory distress syndrome.
Laoag-Fernandez JB; Fernandez AM; Maruo T
J Obstet Gynaecol Res; 2000 Aug; 26(4):307-12. PubMed ID: 11049243
[TBL] [Abstract][Full Text] [Related]
14. Inhalation of ambroxol inhibits cigarette smoke-induced acute lung injury in a mouse model by inhibiting the Erk pathway.
Ge LT; Liu YN; Lin XX; Shen HJ; Jia YL; Dong XW; Sun Y; Xie QM
Int Immunopharmacol; 2016 Apr; 33():90-8. PubMed ID: 26881857
[TBL] [Abstract][Full Text] [Related]
15. [Antioxidative features of ambroxol--usefulness in COPD].
Nowak D
Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
[No Abstract] [Full Text] [Related]
16. Meta-analysis of high doses of ambroxol treatment for acute lung injury/acute respiratory distress syndrome based on randomized controlled trials.
Wu X; Li S; Zhang J; Zhang Y; Han L; Deng Q; Wan X
J Clin Pharmacol; 2014 Nov; 54(11):1199-206. PubMed ID: 25174313
[TBL] [Abstract][Full Text] [Related]
17. Changes in pulmonary function in preterm infants recovering from RDS following early treatment with ambroxol: results of a randomized trial.
Schmalisch G; Wauer RR; Böhme B
Pediatr Pulmonol; 1999 Feb; 27(2):104-12. PubMed ID: 10088933
[TBL] [Abstract][Full Text] [Related]
18. Mucolytics and antioxidant activity.
Strapková A; Nosál'ová G; Franová S
Life Sci; 1999; 65(18-19):1923-5. PubMed ID: 10576438
[TBL] [Abstract][Full Text] [Related]
19. High-dose ambroxol reduces pulmonary complications in patients with acute cervical spinal cord injury after surgery.
Li Q; Yao G; Zhu X
Neurocrit Care; 2012 Apr; 16(2):267-72. PubMed ID: 22006379
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of ambroxol given prenatally and postnatally on gas exchange in the newborn with respiratory distress syndrome].
Sackey S; Gadzinowski J; Szymankiewicz M; Breborowicz GH; Rudnicki J; Patalan J; Rózewicki K
Ginekol Pol; 1995 Jul; 66(7):409-12. PubMed ID: 8655006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]